Views 2,636
Citations 0
Editor's Note
October 03, 2016

Comparing Non–Vitamin K Oral AnticoagulantsWhere We Are Now

Author Affiliations

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. Published online October 3, 2016. doi:10.1001/jamainternmed.2016.6429

In 2016, we have a bevy of oral anticoagulants that are approved for stroke prevention in patients with atrial fibrillation. Non–vitamin K oral anticoagulants (NOACs) are increasingly prescribed, and some guidelines recommend their use over vitamin K antagonists.1 As a consequence, clinicians and patients have more choices and need more data to best balance risks and benefits for each individual.

First Page Preview View Large
First page PDF preview
First page PDF preview